首页> 外文期刊>Regulatory peptides. >Adrenomedullin in the eye.
【24h】

Adrenomedullin in the eye.

机译:眼中的肾上腺髓质素。

获取原文
获取原文并翻译 | 示例
           

摘要

Adrenomedullin (AM) is a multifunctional regulatory peptide that is produced and secreted by various types of cells. We showed the presence of high concentrations of adrenomedullin-immunoreactivity in the vitreous fluid, and the levels were elevated in patients with proliferative vitreoretinopathy. Furthermore, adrenomedullin mRNA expression levels were elevated in the tissues of intraocular tumors and orbital tumors. Adrenomedullin is produced and secreted by cultured human retinal pigment epithelial (RPE) cells. Inflammatory cytokines and hypoxia are strong stimulators for the adrenomedullin expression in retinal pigment epithelial cells. Adrenomedullin stimulated the proliferation of retinal pigment epithelial cells both under normoxia and hypoxia. Dexamethasone (DEX) increased the adrenomedullin expression in two cultured cell lines of human retinal pigment epithelial cells; ARPE-19 cells and D407 cells, while it had no noticeable effects on the cytokine-induced adrenomedullin expression. These findings suggest that adrenomedullin is involved in the pathophysiology of inflammatory and neoplastic eye diseases as an autocrine or paracrine growth stimulator. The findings on glucocorticoid-induced AM expression raise the possibility that it may be related to the pathogenesis of some eye diseases, such as central serous chorioretinopathy and multifocal posterior pigment epitheliopathy, which are frequently seen in patients treated with high doses of glucocorticoids.
机译:肾上腺髓质素(AM)是一种多功能调节肽,由各种类型的细胞产生和分泌。我们发现玻璃体液中存在高浓度的肾上腺髓质素免疫反应性,增生性玻璃体视网膜病变患者的水平升高。此外,眼内肿瘤和眼眶肿瘤的组织中肾上腺髓质素mRNA表达水平升高。肾上腺髓质素由培养的人视网膜色素上皮细胞(RPE)产生和分泌。炎症细胞因子和低氧是视网膜色素上皮细胞中肾上腺髓质素表达的强烈刺激剂。在常氧和低氧条件下,肾上腺髓质素刺激视网膜色素上皮细胞的增殖。地塞米松(DEX)在人视网膜色素上皮细胞的两种培养细胞系中增加了肾上腺髓质素的表达。 ARPE-19细胞和D407细胞,虽然对细胞因子诱导的肾上腺髓质素表达没有明显影响。这些发现表明肾上腺髓质素作为自分泌或旁分泌生长刺激物参与了炎性和赘生性眼病的病理生理。糖皮质激素诱导的AM表达的发现增加了它可能与某些眼部疾病的发病机制有关的可能性,例如中性浆液性脉络膜脉络膜视网膜病变和多灶性后色素上皮病变,这在高剂量糖皮质激素治疗的患者中经常见到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号